Literature DB >> 7437642

Histamine weal formation and absorption in man.

J Cook, S Shuster.   

Abstract

1 The weal and flare response to intradermal histamine was measured over a range of doses in forearm skin of man. 2 The use of calipers to measure weal thickness was validated by measurement of observer and method errors. Repeated measurements at intervals of 5 min or more compressed the weals by 6% per reading. 3 Flare response reached a maximum at 5 min compared with 20 min for weal thickness and the sensitivity of the flare response was greater than the weal response at lower doses of histamine. 4 Sensitivity, lambda was comparable for the measurement of flare, weal diameter and thickness or volume. The advantage of weal thickness was in the measurement of weal formation and resorption. 5 The time course of histamine weal formation and disappearance was measured and found to have a T1/2 of 5.4 min and 87 min, respectively. 6 The T1/2 of disappearance of comparable 09% w/v NaCl solution and serum weals were 18 and 28 min respectively. 7 It is suggested that persistence of histamine weals is due to a vasoactive agent other than histamine.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7437642      PMCID: PMC2044312          DOI: 10.1111/j.1476-5381.1980.tb07907.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  3 in total

1.  Vascular reactions to histamine, histamine-liberator and leukotaxine in the skin of guinea-pigs.

Authors:  A A MILES; E M MILES
Journal:  J Physiol       Date:  1952-10       Impact factor: 5.182

2.  The action of pharmacologically active substances on the flow and composition of cat hind limb lymph.

Authors:  G P Lewis; N J Winsey
Journal:  Br J Pharmacol       Date:  1970-11       Impact factor: 8.739

3.  Responses of skin blood vessels to bradykinin, histamine and 5-hydroxytryptamine.

Authors:  M Greaves; S Shuster
Journal:  J Physiol       Date:  1967-11       Impact factor: 5.182

  3 in total
  15 in total

1.  The effect of indomethacin on the kinetics of histamine, 48/80 and antigen wealing.

Authors:  F Humphreys; S Shuster
Journal:  Br J Clin Pharmacol       Date:  1990-02       Impact factor: 4.335

2.  A double-blind placebo controlled dose response study of noberastine on histamine induced weal and flare.

Authors:  F Kamali; M Emanuel; M D Rawlins
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

3.  The basis of the histamine assay in skin.

Authors:  H Byrom; M Clark; V White; D W Vere
Journal:  Br J Clin Pharmacol       Date:  1991-09       Impact factor: 4.335

4.  Effect of captopril on skin blood flow following intradermal bradykinin measured by laser Doppler flowmetry.

Authors:  T C Li Kam Wa; N E Almond; E D Cooke; P Turner
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

5.  Effects of intradermal bradykinin after inhibition of angiotensin converting enzyme.

Authors:  R E Ferner; J M Simpson; M D Rawlins
Journal:  Br Med J (Clin Res Ed)       Date:  1987-05-02

6.  Quantitative relationships between sensitizing dose of DNCB and reactivity in normal subjects.

Authors:  P S Friedmann; C Moss; S Shuster; J M Simpson
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

7.  The effects of astemizole on histamine-induced weal and flare.

Authors:  D N Bateman; P H Chapman; M D Rawlins
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

8.  A comparison of the effects of captopril and enalapril on skin responses to intradermal bradykinin and skin blood flow in the human forearm.

Authors:  T C Li Kam Wa; E D Cooke; P Turner
Journal:  Br J Clin Pharmacol       Date:  1993-01       Impact factor: 4.335

9.  Effects of intradermal injection of atrial natriuretic peptide.

Authors:  A M Sharara; M A Higham; A Spanevello; P W Ind
Journal:  Br J Clin Pharmacol       Date:  1995-09       Impact factor: 4.335

10.  Cutaneous blood flow changes and weal induced by intradermal bradykinin following pretreatment with indomethacin and captopril.

Authors:  T C Wa; E D Cooke; P Turner
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.